Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 5
Submit an article Journal homepage
221
Views
33
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics

Kenji FukunoFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
,
Takeshi HaraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
,
Hisashi TsurumiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, JapanCorrespondence[email protected]
,
Yuhei ShibataFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
,
Ryoko MabuchiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
,
Nobuhiko NakamuraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
,
Junichi KitagawaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
,
Masahito ShimizuFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
,
Hiroyasu ItoDepartment of Informative Clinical Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
,
Kuniaki SaitoHuman Health Sciences, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan
&
Hisataka MoriwakiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
 show all
Pages 1398-1405 | Received 29 Jan 2014, Accepted 04 Aug 2014, Published online: 03 Nov 2014

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Mansour Alfayez & Gautam Borthakur. (2018) Checkpoint inhibitors and acute myelogenous leukemia: promises and challenges. Expert Review of Hematology 11:5, pages 373-389.
Read now
Pilvi Maliniemi, Kirsi Laukkanen, Liisa Väkevä, Katja Dettmer, Tuomas Lipsanen, Leila Jeskanen, Alban Bessede, Peter J. Oefner, Marshall E. Kadin & Annamari Ranki. (2017) Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas. OncoImmunology 6:3.
Read now
Takeshi Hara, Takuro Matsumoto, Yuhei Shibata, Nobuhiko Nakamura, Hiroshi Nakamura, Soranobu Ninomiya, Junichi Kitagawa, Yasuhito Nannya, Masahito Shimizu, Hiroyasu Ito, Kuniaki Saito & Hisashi Tsurumi. (2016) Prognostic value of the combination of serum l-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia. Leukemia & Lymphoma 57:9, pages 2208-2211.
Read now
Ryoko Mabuchi, Takeshi Hara, Takuro Matsumoto, Yuhei Shibata, Nobuhiko Nakamura, Hiroshi Nakamura, Junichi Kitagawa, Nobuhiro Kanemura, Naoe Goto, Masahito Shimizu, Hiroyasu Ito, Yasuko Yamamoto, Kuniaki Saito, Hisataka Moriwaki & Hisashi Tsurumi. (2016) High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia. Leukemia & Lymphoma 57:1, pages 92-98.
Read now

Articles from other publishers (29)

Tatjana Sauerer, Giuliano Filippini Velázquez & Christoph Schmid. (2023) Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy. Molecular Cancer 22:1.
Crossref
Jolien Vanhooren, Rani Dobbelaere, Charlotte Derpoorter, Larissa Deneweth, Laurens Van Camp, Anne Uyttebroeck, Barbara De Moerloose & Tim Lammens. (2023) CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them. HemaSphere 7:9, pages e937.
Crossref
Marta Galán-Díez, Florence Borot, Abdullah Mahmood Ali, Junfei Zhao, Eva Gil-Iturbe, Xiaochuan Shan, Na Luo, Yongfeng Liu, Xi-Ping Huang, Brygida Bisikirska, Rossella Labella, Irwin Kurland, Bryan L. Roth, Matthias Quick, Siddhartha Mukherjee, Raul Rabadán, Martin Carroll, Azra Raza & Stavroula Kousteni. (2022) Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia. Cancer Discovery 12:4, pages 1106-1127.
Crossref
Simone Ragaini, Sarah Wagner, Giovanni Marconi, Sarah ParisiChiara Sartor, Jacopo NanniGianluca CristianoAnnalisa TalamiMatteo OliviDarina OcadlikovaMarilena Ciciarello, Giulia CorradiEmanuela Ottaviani, Cristina Papayannidis, Stefania Paolini, Jayakumar VadakekolathuMichele Cavo, Sergio Rutella & Antonio Curti. (2022) An IDO1 -related immune gene signature predicts overall survival in acute myeloid leukemia . Blood Advances 6:1, pages 87-99.
Crossref
Mojdeh Soltani, Yue Zhao, Zhijia Xia, Mazdak Ganjalikhani Hakemi & Alexandr V. Bazhin. (2021) The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies. Frontiers in Oncology 11.
Crossref
Ludovica Di Martino, Valeria Tosello, Edoardo Peroni & Erich Piovan. (2021) Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia. International Journal of Molecular Sciences 22:16, pages 8738.
Crossref
Julian Swatler, Laura Turos-Korgul, Ewa Kozlowska & Katarzyna Piwocka. (2021) Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias. Cancers 13:6, pages 1203.
Crossref
Georgia Wells, Paul T. Kennedy & Lekh N. Dahal. (2021) Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review. Frontiers in Immunology 12.
Crossref
Sophia Khaldoyanidi, Dirk Nagorsen, Anthony Stein, Gerrit Ossenkoppele & Marion Subklewe. (2021) Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy. Journal of Clinical Oncology 39:5, pages 419-432.
Crossref
Matthew R. Lordo, Steven D. Scoville, Akul Goel, Jianhua Yu, Aharon G. Freud, Michael A. Caligiuri & Bethany L. Mundy-Bosse. (2021) Unraveling the Role of Innate Lymphoid Cells in Acute Myeloid Leukemia. Cancers 13:2, pages 320.
Crossref
Melinda A. Biernacki, Kimberly A. Foster, Kyle B. Woodward, Michael E. Coon, Carrie Cummings, Tanya M. Cunningham, Robson G. Dossa, Michelle Brault, Jamie Stokke, Tayla M. Olsen, Kelda Gardner, Elihu Estey, Soheil Meshinchi, Anthony Rongvaux & Marie Bleakley. (2020) CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia. Journal of Clinical Investigation 130:10, pages 5127-5141.
Crossref
Zhuoyan Li, Mary Philip & P. Brent Ferrell. (2020) Alterations of T-cell-mediated immunity in acute myeloid leukemia. Oncogene 39:18, pages 3611-3619.
Crossref
Soranobu Ninomiya, Nobuhiko Nakamura, Hiroshi Nakamura, Taku Mizutani, Yuto Kaneda, Kimihiro Yamaguchi, Takuro Matsumoto, Junichi Kitagawa, Nobuhiro Kanemura, Makoto Shiraki, Takeshi Hara, Masahito Shimizu & Hisashi Tsurumi. (2020) Low Levels of Serum Tryptophan Underlie Skeletal Muscle Atrophy. Nutrients 12:4, pages 978.
Crossref
Luca Vago & Ivana Gojo. (2020) Immune escape and immunotherapy of acute myeloid leukemia. Journal of Clinical Investigation 130:4, pages 1552-1564.
Crossref
Lukas Lanser, Patricia Kink, Eva Maria Egger, Wolfgang Willenbacher, Dietmar Fuchs, Guenter Weiss & Katharina Kurz. (2020) Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer. Frontiers in Immunology 11.
Crossref
Melinda A. Biernacki & Marie Bleakley. (2020) Neoantigens in Hematologic Malignancies. Frontiers in Immunology 11.
Crossref
Dimitrios Mougiakakos. (2019) The Induction of a Permissive Environment to Promote T Cell Immune Evasion in Acute Myeloid Leukemia: The Metabolic Perspective. Frontiers in Oncology 9.
Crossref
Fanni A. Boros & László Vécsei. (2019) Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway. Frontiers in Immunology 10.
Crossref
Melinda A. Biernacki, Michelle Brault & Marie Bleakley. (2019) T-Cell Receptor–Based Immunotherapy for Hematologic Malignancies. The Cancer Journal 25:3, pages 179-190.
Crossref
Steven D. ScovilleAnsel P. NalinLuxi ChenLi ChenMichael H. ZhangKathleen McConnellSusana Beceiro CasasGabrielle ErnstAbd Al-Rahman TraboulsiNaima HashiMonica WilliamsXiaoli ZhangTiffany HughesAnjali Mishra, Don M. BensonJennifer N. SaultzJianhua YuAharon G. Freud, Michael A. Caligiuri & Bethany L. Mundy-Bosse. (2018) Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function. Blood 132:17, pages 1792-1804.
Crossref
Adam J. Lamble & Evan F. Lind. (2018) Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity. Frontiers in Oncology 8.
Crossref
Jitske van den Bulk, Els ME Verdegaal & Noel FCC de Miranda. (2018) Cancer immunotherapy: broadening the scope of targetable tumours. Open Biology 8:6.
Crossref
Diwakar Davar & Nathan Bahary. (2018) Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences. Targeted Oncology 13:2, pages 125-140.
Crossref
Felicia Rubel, Johannes S. Kern, Kristin Technau-Hafsi, Sibylle Uhrich, Kaethe Thoma, Georg Häcker, Nikolas von Bubnoff, Frank Meiss & Dagmar von Bubnoff. (2018) Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival. Journal of Investigative Dermatology 138:3, pages 679-687.
Crossref
Nargess ArandiMani RamziFatemeh SafaeiAhmad Monabati. (2018) Overexpression of indoleamine 2,3-dioxygenase correlates with regulatory T cell phenotype in acute myeloid leukemia patients with normal karyotype. Blood Research 53:4, pages 294.
Crossref
Seyedeh Nafiseh Hassani, Hadi Rezaeeyan, Asma Ghodsi & Najmaldin Saki. (2017) Restoration of natural killer cell cytotoxicity in the suppressive tumor microenvironment: novel approaches to treat AML. Journal of Hematopathology 10:3-4, pages 109-116.
Crossref
Carmen S. Yong, Daouda Abba Moussa, Gaspard Cretenet, Sandrina Kinet, Valérie Dardalhon & Naomi Taylor. (2017) Metabolic orchestration of T lineage differentiation and function. FEBS Letters 591:19, pages 3104-3118.
Crossref
Mark Yarchoan, Burles A. JohnsonIIIIII, Eric R. Lutz, Daniel A. Laheru & Elizabeth M. Jaffee. (2017) Targeting neoantigens to augment antitumour immunity. Nature Reviews Cancer 17:4, pages 209-222.
Crossref
Yuhei Shibata, Takeshi Hara, Junji Nagano, Nobuhiko Nakamura, Tomohiko Ohno, Soranobu Ninomiya, Hiroyasu Ito, Takuji Tanaka, Kuniaki Saito, Mitsuru Seishima, Masahito Shimizu, Hisataka Moriwaki & Hisashi Tsurumi. (2016) The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis. PLOS ONE 11:1, pages e0146279.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.